2016
DOI: 10.1136/thoraxjnl-2015-208027
|View full text |Cite
|
Sign up to set email alerts
|

Aminoglycoside resistance ofPseudomonas aeruginosain cystic fibrosis results from convergent evolution in themexZgene

Abstract: Rationale Aminoglycoside (AG) resistance by Pseudomonas aeruginosa in Cystic Fibrosis is associated with poorer clinical outcomes and is usually due to overexpression of the efflux pump MexXY. MexXY is regulated by mexZ, one of the most commonly mutated genes in CF P. aeruginosa isolates. Little is known about the evolutionary relationship between AG resistance, MexXY expression and mexZ mutations. Objectives To test the hypothesis that AG resistance in P. aeruginosa develops in parallel with higher MexXY ex… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

5
40
1

Year Published

2018
2018
2024
2024

Publication Types

Select...
5
2
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 53 publications
(46 citation statements)
references
References 34 publications
(23 reference statements)
5
40
1
Order By: Relevance
“…There was high variation in the expression of both ampC (over 20,000-fold) and mexX (2,000-fold) among isolates of P. aeruginosa grown on laboratory agar. Other researchers have also reported extensive variation in the expression of these genes among isolates of P. aeruginosa from a number of clinical settings (25,27,30,(39)(40)(41), reflecting the frequent occurrence of mutations that result in upregulation of ampC and mexX in clinical isolates of P. aeruginosa (22)(23)(24)(25)(26)(27)(28)(29)(30)(31). Meropenem increased the expression of ampC, and tobramycin increased expression of mexX in the isolates in our study.…”
Section: Discussionsupporting
confidence: 71%
See 1 more Smart Citation
“…There was high variation in the expression of both ampC (over 20,000-fold) and mexX (2,000-fold) among isolates of P. aeruginosa grown on laboratory agar. Other researchers have also reported extensive variation in the expression of these genes among isolates of P. aeruginosa from a number of clinical settings (25,27,30,(39)(40)(41), reflecting the frequent occurrence of mutations that result in upregulation of ampC and mexX in clinical isolates of P. aeruginosa (22)(23)(24)(25)(26)(27)(28)(29)(30)(31). Meropenem increased the expression of ampC, and tobramycin increased expression of mexX in the isolates in our study.…”
Section: Discussionsupporting
confidence: 71%
“…␤-Lactam antibiotics increase expression of the ampC gene, and aminoglycoside substrates increase expression of the mexXY genes, which are expressed as an operon (21). P. aeruginosa isolates cultured from individuals with CF commonly possess genetic mutations that give rise to increased ampC and mexXY expression and are associated with increased ␤-lactam and aminoglycoside antibiotic resistance (22)(23)(24)(25)(26)(27)(28)(29)(30)(31).…”
mentioning
confidence: 99%
“…MIC determinations showed that all isolates, except for 1991 and 1995, became resistant to tobramycin. The main origin of high-level resistance to aminoglycosides is the overexpression of MexXY-OprM efflux system (50), which is primarily caused by mexZ mutations (10, 21, 51). In addition, mutations in the amgRS and parRS two-component systems genes have also been involved in the regulation of MexXY expression (52).…”
Section: Resultsmentioning
confidence: 99%
“…Additional pumps known to impact susceptibility to antibiotics are MexXY (OprM), which is inducible by antibiotics that inhibit protein synthesis (13)(14)(15)(16), and MexCD-OprJ and MexEF-OprN, which are typically silent but which can be strongly upregulated in so-called nfxB (17)(18)(19) and nfxC (20)(21)(22) mutants, respectively. Regulatory mutations (e.g., in the repressor gene mexZ) or mutations that interfere with protein synthesis can also lead to the constitutive expression of MexXY and corresponding reductions in susceptibility to antibiotics (13,16,(23)(24)(25)(26)(27)(28). Overexpression of these and other pumps has been found in clinical isolates, presumably selected by therapeutic exposure to antibiotics (2).…”
mentioning
confidence: 99%